Li Kang Biomedical Co Stock

Li Kang Biomedical Co P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Li Kang Biomedical Co (6242.TWO) as of Aug 10, 2026 is 13.22. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 18.63 — a change of -29.05% (lower).

P/CF

13.22

YoY

-29.05%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Li Kang Biomedical Co is 2026 13.22 . P/CF (Price-to-Cash-Flow Ratio) of Li Kang Biomedical Co was 2025 18.63 . It decreases by -29.05% lower compared to the previous year.
Access this data via the Eulerpool API

Li Kang Biomedical Co Stock analysis

What does Li Kang Biomedical Co do? Li Kang Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Li Kang Biomedical Co stock

P/CF (Price-to-Cash-Flow Ratio) of Li Kang Biomedical Co is 13.22 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of Li Kang Biomedical Co changed from 18.63 to 13.22, representing a -29.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Li Kang Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Li Kang Biomedical Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Li Kang Biomedical Co

All Key Metrics — Li Kang Biomedical Co